Please use this identifier to cite or link to this item:
Title: A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
Austin Authors: Fealy, Nigel G ;Baldwin, Ian C ;Johnstone, M;Egi, Moritoki;Bellomo, Rinaldo 
Affiliation: Department of Intensive Care, Austin Hospital, Melbourne - Australia
Issue Date: 1-Apr-2007
Publication information: The International Journal of Artificial Organs; 30(4): 301-7
Abstract: To evaluate the efficacy and safety of a regional heparinization and a regional citrate method of anticoagulation in CVVH.Randomized controlled cross-over study.Ten critically ill patients with acute renal failure.ICU of tertiary hospital.CVVH was performed with pre-filter fluid replacement at 2000 ml/h and a blood flow rate of 150 ml/min. Regional heparinization was by the administration of heparin pre-filter at 1500 IU/h and protamine post-filter at 15 mg/h. Regional citrate anticoagulation was by means of a citrate-based replacement fluid (14 mmol/L) administered pre-dilution.We studied nine males and one female. The mean age and APACHE II score were 70.5 and 17 respectively. Median circuit life was 13 hours (IQR 9.28) for the regional heparinization method compared to 17 hours (IQR 12,19.5) for the regional citrate method (p=0.77). There were no episodes of bleeding in either group.Regional heparinization and regional citrate anticoagulation achieve similar circuit life in critically ill patients receiving CVVH.
Gov't Doc #: 17520566
Type: Journal Article
Subjects: Acute Kidney Injury.therapy
Aged, 80 and over
Anticoagulants.therapeutic use
Calcium.therapeutic use
Citric Acid.therapeutic use
Cross-Over Studies
Hemodialysis Solutions.therapeutic use
Heparin.therapeutic use
Heparin Antagonists.therapeutic use
Intensive Care
Magnesium.therapeutic use
Middle Aged
Pilot Projects
Protamines.therapeutic use
Time Factors
Treatment Outcome
Appears in Collections:Journal articles

Show full item record

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.